Patient in the lab: predicting clinical responses using patient-derived organoid screening

June 3, 2022

Patient in the lab: predicting clinical responses using patient-derived organoid screening

Adult epithelial stem cell-derived organoids (HUB Organoids™) are proving to be a major breakthrough in preclinical models. HUB Organoids are fundamentally changing...

read more

Patient-derived organoids predict clinical response: a patient in the lab

June 3, 2022

Patient-derived organoids predict clinical response: a patient in the lab

Colorectal cancer (CRC) is the third leading cause of cancer and cancer-related death. A large fraction of the CRC patients diagnosed with...

read more

Application of HUB Organoids® to Immunotherapy development

June 3, 2022

Application of HUB Organoids® to Immunotherapy development

Poster P03: Autologous organoid and T cell co-cultures as a powerful personalized platform for Immunotherapy development

read more

EUROTOX 2021 | Poster 391

February 17, 2022

EUROTOX 2021 | Poster 391

Discover how to reduce costly animal experiments and obtain a quick indication of your drug safety with Merel Derksen. Poster 391: Intestinal organoids as in vitro model...

read more

EUROTOX 2021 | Poster 553

February 17, 2022

EUROTOX 2021 | Poster 553

Dr. Pourfarzad presents data on the use of HUB Organoids as advanced modes to investigate ADME and safety. Poster 553: HUB Organoids™ improve preclinical toxicology, metabolism, and...

read more

X

Have any questions?

contact us